{
    "immunity": null,
    "contraindications": {
        "vaccineGroup": {
            "groupContraindication": [
                {
                    "observationCode": "080",
                    "observationTitle": "Adverse reaction to vaccine component",
                    "contraindicationText": "Do not vaccinate if the patient has had an adverse reaction to a vaccine component.",
                    "contraindicationGuidance": null,
                    "beginAge": null,
                    "endAge": null
                },
                {
                    "observationCode": "119",
                    "observationTitle": "Severe allergic reaction after previous dose of cholera",
                    "contraindicationText": "Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of cholera vaccine.",
                    "contraindicationGuidance": null,
                    "beginAge": null,
                    "endAge": null
                }
            ]
        }
    },
    "series": [
        {
            "seriesName": "Cholera 1-dose series",
            "targetDisease": "Cholera",
            "seriesVaccineGroup": "Cholera ",
            "seriesAdminGuidance": "No data exist on use of the currently available lyophilized CVD 103-HgR formulation in immunocompromised populations.",
            "seriesType": "Risk",
            "equivalentSeriesGroups": null,
            "requiredGender": null,
            "defaultSeries": "No",
            "productPath": "No",
            "seriesGroupName": "Increased Risk",
            "seriesGroup": "1",
            "seriesPriority": "A",
            "seriesPreference": "1",
            "minAgeToStart": "18 years",
            "maxAgeToStart": "65 years",
            "indication": [
                {
                    "observationCode": {
                        "text": "Travel to an area of active cholera transmission",
                        "code": "008"
                    },
                    "description": "Administer to adult travelers (aged 18-64 years) from the United States traveling to an area of active cholera transmission.",
                    "beginAge": "18 years",
                    "endAge": "65 years",
                    "guidance": null
                }
            ],
            "seriesDose": [
                {
                    "doseNumber": 1,
                    "age": [
                        {
                            "absMinAge": "18 years - 4 days",
                            "minAge": "18 years",
                            "earliestRecAge": "18 years",
                            "latestRecAge": null,
                            "maxAge": null,
                            "effectiveDate": null,
                            "cessationDate": null
                        }
                    ],
                    "interval": null,
                    "allowableInterval": null,
                    "preferableVaccine": [
                        {
                            "vaccineType": "cholera, live attenuated",
                            "cvx": "174",
                            "beginAge": "18 years",
                            "endAge": "65 years",
                            "tradeName": null,
                            "mvx": null,
                            "volume": "100",
                            "forecastVaccineType": "N"
                        }
                    ],
                    "allowableVaccine": [
                        {
                            "vaccineType": "cholera, live attenuated",
                            "cvx": "174",
                            "beginAge": "18 years - 4 days",
                            "endAge": null
                        }
                    ],
                    "inadvertentVaccine": null,
                    "conditionalSkip": null,
                    "recurringDose": "No",
                    "seasonalRecommendation": null
                }
            ]
        }
    ]
}